← Eichor
Condition: Pleural Mesotheliomas Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Pleural Mesotheliomas

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The IMmunotherapy Pleural 5-ALA PDT
Phase 2 · 1 location(s) · University Hospital, Lille · NCT04400539Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
Phase 1 · 1 location(s) · David Bartlett, MD · NCT07192900The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma
Phase 2 · 1 location(s) · Aalborg University Hospital · NCT06790082Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma
Phase 1/Phase 2 · 1 location(s) · Beijing Biotech · NCT07510815First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma
Phase 2 · 2 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT05188859dENdritic Cell Therapy Combined With SURgEry in Mesothelioma
Phase 1 · 1 location(s) · Erasmus Medical Center · NCT05304208Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma
Phase 2 · 132 location(s) · Alliance for Clinical Trials in Oncology · NCT05647265A Study of Sacituzumab Govitecan in People With Mesothelioma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06477419Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
NA · 1 location(s) · Brigham and Women's Hospital · NCT06538376NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a F
Phase 1/Phase 2 · 1 location(s) · University Hospital, Antwerp · NCT07121374Identification of Prognostic and Predictive Biomarkers of Toxicity in Patients With Malignant Pleural Mesothelioma and T
Phase N/A · 1 location(s) · Centro di Riferimento Oncologico - Aviano · NCT06637345A Study of NX-1607 in Adults With Advanced Malignancies
Phase 1 · 17 location(s) · Nurix Therapeutics, Inc. · NCT05107674TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
Phase N/A · 1 location(s) · University College, London · NCT05628376Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic
Phase 2 · 97 location(s) · AstraZeneca · NCT06535607Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
Phase 1 · 1 location(s) · Abramson Cancer Center at Penn Medicine · NCT03760575Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors
Phase 1 · 1 location(s) · Allegheny Singer Research Institute (also known as Allegheny · NCT07443020First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis.
NA · 1 location(s) · National and Kapodistrian University of Athens · NCT06946498Multidimensional Omics Analysis in Malignant Pleural Mesothelioma
Phase N/A · 4 location(s) · Azienda USL Reggio Emilia - IRCCS · NCT07561190Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma
NA · 1 location(s) · University of Chicago · NCT07126509Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural Mesothelioma
Phase 2 · 1 location(s) · The First Hospital of Jilin University · NCT06875076CT-95 in Advanced Cancers Associated With Mesothelin Expression
Phase 1 · 9 location(s) · Context Therapeutics Inc. · NCT06756035A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Phase 1/Phase 2 · 5 location(s) · 7 Hills Pharma, LLC · NCT06362369A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1 · 16 location(s) · IDEAYA Biosciences · NCT07277413A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
Phase 2 · 13 location(s) · Memorial Sloan Kettering Cancer Center · NCT06057935Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previo
Phase 2 · 20 location(s) · Intergroupe Francophone de Cancerologie Thoracique · NCT06840834A Beta-only IL-2 ImmunoTherapY Study
Phase 1/Phase 2 · 27 location(s) · Medicenna Therapeutics, Inc. · NCT05086692Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural Mesothelioma
Phase N/A · 1 location(s) · Tianjin Medical University Second Hospital · NCT06031636A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors
Phase 1/Phase 2 · 12 location(s) · A2 Biotherapeutics Inc. · NCT06051695Evaluation of Skin Tests in Biotherapy Allergies
NA · 1 location(s) · University Hospital, Angers · NCT06971848Olaparib in Patients With HRD Malignant Mesothelioma
Phase 2 · 1 location(s) · University of Chicago · NCT04515836
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.